Kim R Tsuchimoto - Net Worth and Insider Trading
Kim R Tsuchimoto Net Worth
The estimated net worth of Kim R Tsuchimoto is at least $8,056 dollars as of 2025-05-06. Kim R Tsuchimoto is the CFO of Raptor Pharmaceutical Corp and owns about 582 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $5,238. Kim R Tsuchimoto is also the CFO of Monopar Therapeutics Inc and owns about 65 shares of Monopar Therapeutics Inc (MNPR) stock worth over $2,818. Details can be seen in Kim R Tsuchimoto's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kim R Tsuchimoto has not made any transactions after 2019-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kim R Tsuchimoto
Kim R Tsuchimoto Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kim R Tsuchimoto owns 3 companies in total, including Monopar Therapeutics Inc (MNPR) , Raptor Pharmaceutical Corp (RPTP) , and Spatialight Inc (SPLT) .
Click here to see the complete history of Kim R Tsuchimoto’s form 4 insider trades.
Insider Ownership Summary of Kim R Tsuchimoto
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
MNPR | Monopar Therapeutics Inc | 2022-12-31 | Chief Financial Officer |
RPTP | Raptor Pharmaceutical Corp | 2012-09-25 | other: Vice President Finance |
SPLT | Spatialight Inc | 2005-08-01 | Prin Financial & Acctg Officer |
Kim R Tsuchimoto Latest Holdings Summary
Kim R Tsuchimoto currently owns a total of 2 stocks. Among these stocks, Kim R Tsuchimoto owns 582 shares of Raptor Pharmaceutical Corp (RPTP) as of August 29, 2012, with a value of $5,238 and a weighting of 65.02%. Kim R Tsuchimoto also owns 65 shares of Monopar Therapeutics Inc (MNPR) as of December 18, 2019, with a value of $2,818 and a weighting of 34.98%.
Latest Holdings of Kim R Tsuchimoto
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RPTP | Raptor Pharmaceutical Corp | 2012-08-29 | 582 | 9.00 | 5,238 |
MNPR | Monopar Therapeutics Inc | 2019-12-18 | 65 | 43.36 | 2,818 |
Holding Weightings of Kim R Tsuchimoto
Kim R Tsuchimoto Form 4 Trading Tracker
According to the SEC Form 4 filings, Kim R Tsuchimoto has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 3,510 shares on August 29, 2012, which brought Kim R Tsuchimoto around $17,550.
According to the SEC Form 4 filings, Kim R Tsuchimoto has made a total of 0 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 65 shares on December 18, 2019, which cost Kim R Tsuchimoto around $2,600.
Insider Trading History of Kim R Tsuchimoto
- 1
Kim R Tsuchimoto Trading Performance
Kim R Tsuchimoto Ownership Network
Ownership Network List of Kim R Tsuchimoto
Ownership Network Relation of Kim R Tsuchimoto

Kim R Tsuchimoto's Compensation Overview
Company | Year | Salary($) | Bonus($) | Stock Awards($) | Option Awards($) | Equity Awards($) | Non-Equity Incentive Plan($) | All Other Compensation($) | Change in Pension and Deferred Comp($) | Total($) |
---|---|---|---|---|---|---|---|---|---|---|
Monopar Therapeutics Inc | 2023 | 300,000 | N/A | 247,219 | 247,221 | N/A | 54,000 | 0 | N/A | 848,441 |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
Kim R Tsuchimoto Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Kim R Tsuchimoto is the Chief Financial Officer of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include 10 percent owner Tactic Pharma Llc , Chief Operating Officer Andrew Cittadine , and director & Chief Executive Officer Chandler Robinson .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Kim R Tsuchimoto made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 128,508 shares made by Andrew Cittadine , a net sale of 33,334 shares made by Tactic Pharma Llc , and a net purchase of 1,550 shares made by Karthik Radhakrishnan .
In summary, during the past 3 months, insiders sold 33,334 shares of Monopar Therapeutics Inc (MNPR) in total and bought 0 shares, with a net sale of 33,334 shares. During the past 18 months, 33,334 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net sale of 6,082 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Kim R Tsuchimoto Mailing Address
Above is the net worth, insider trading, and ownership report for Kim R Tsuchimoto. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kim R Tsuchimoto's mailing address is: Wilmette Il 60091.